Unaltered secretion of beta-amyloid precursor protein in gelatinase A (matrix metalloproteinase 2)-deficient mice
- PMID: 9278386
- DOI: 10.1074/jbc.272.36.22389
Unaltered secretion of beta-amyloid precursor protein in gelatinase A (matrix metalloproteinase 2)-deficient mice
Abstract
The beta-amyloid peptide, which forms extracellular cerebral deposits in Alzheimer's disease, is derived from a large membrane-spanning glycoprotein referred to as the beta-amyloid precursor protein (APP). The APP is normally cleaved within the beta-amyloid region by a putative proteinase (alpha-secretase) to generate large soluble amino-terminal derivatives of APP, and this event prevents the beta-amyloid peptide formation. It has been suggested that the gelatinase A (matrix metalloproteinase 2, a 72-kDa type IV collagenase) may act either as alpha-secretase or as beta-secretase. Mice devoid of gelatinase A generated by gene targeting develop normally, except for a subtle delay in their growth, thus providing a useful system to examine the role of gelatinase A in the cleavage and secretion of APP in vivo. We show here that APP is cleaved within the beta-amyloid region and secreted into the extracellular milieu of brain and cultured fibroblasts without gelatinase A activity. The data suggest that gelatinase A does not play an essential role in the generation and release of soluble derivatives of APP at physiological conditions.
Similar articles
-
Gelatinase A possesses a beta-secretase-like activity in cleaving the amyloid protein precursor of Alzheimer's disease.FEBS Lett. 1995 Dec 18;377(2):267-70. doi: 10.1016/0014-5793(95)01358-x. FEBS Lett. 1995. PMID: 8543065
-
A metalloproteinase inhibitor domain in Alzheimer amyloid protein precursor.Nature. 1993 Apr 29;362(6423):839-41. doi: 10.1038/362839a0. Nature. 1993. PMID: 8479521
-
Gelatinase A not alpha-secretase?Nature. 1994 Jan 6;367(6458):27-8. doi: 10.1038/367027a0. Nature. 1994. PMID: 7906388 No abstract available.
-
The regulation of amyloid precursor protein metabolism by cholinergic mechanisms and neurotrophin receptor signaling.Prog Neurobiol. 1998 Dec;56(5):541-69. doi: 10.1016/s0301-0082(98)00044-6. Prog Neurobiol. 1998. PMID: 9775403 Review.
-
The search for alpha-secretase and its potential as a therapeutic approach to Alzheimer s disease.Curr Med Chem. 2002 Jun;9(11):1107-19. doi: 10.2174/0929867023370121. Curr Med Chem. 2002. PMID: 12052175 Review.
Cited by
-
The endogenous zinc finger transcription factor, ZNF24, modulates the angiogenic potential of human microvascular endothelial cells.FASEB J. 2015 Apr;29(4):1371-82. doi: 10.1096/fj.14-258947. Epub 2014 Dec 30. FASEB J. 2015. PMID: 25550468 Free PMC article.
-
Craniofacial tendon development-Characterization of extracellular matrix morphology and spatiotemporal protein distribution.Front Cell Dev Biol. 2022 Sep 7;10:944126. doi: 10.3389/fcell.2022.944126. eCollection 2022. Front Cell Dev Biol. 2022. PMID: 36158210 Free PMC article.
-
Matrix metalloproteinases 2 and 9 work in concert to produce aortic aneurysms.J Clin Invest. 2002 Sep;110(5):625-32. doi: 10.1172/JCI15334. J Clin Invest. 2002. PMID: 12208863 Free PMC article.
-
Type I collagen is a genetic modifier of matrix metalloproteinase 2 in murine skeletal development.Dev Dyn. 2007 Jun;236(6):1683-93. doi: 10.1002/dvdy.21159. Dev Dyn. 2007. PMID: 17440987 Free PMC article.
-
Inactivation of chemokine (C-C motif) receptor 1 (CCR1) suppresses colon cancer liver metastasis by blocking accumulation of immature myeloid cells in a mouse model.Proc Natl Acad Sci U S A. 2010 Jul 20;107(29):13063-8. doi: 10.1073/pnas.1002372107. Epub 2010 Jun 29. Proc Natl Acad Sci U S A. 2010. PMID: 20616008 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
